title: Stroke therapy in patients considering prothrombin time and international normalized ratio.
authors.forename: Karen
authors.initials: K
authors.lastname: Albright
authors.forename: Andrew
authors.initials: A
authors.lastname: Stemer
authors.forename: Gilda
authors.initials: G
authors.lastname: Tafreshi
authors.forename: Thomas
authors.initials: T
authors.lastname: Hemmen
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000150:complications; D004632:Emergency Medical Services; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D011517:Prothrombin Time; D020521:Stroke / Q000175:diagnosis* / Q000209:etiology / Q000378:metabolism* / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator